全文获取类型
收费全文 | 23064篇 |
免费 | 1859篇 |
国内免费 | 690篇 |
专业分类
耳鼻咽喉 | 150篇 |
儿科学 | 556篇 |
妇产科学 | 239篇 |
基础医学 | 2464篇 |
口腔科学 | 336篇 |
临床医学 | 2841篇 |
内科学 | 3587篇 |
皮肤病学 | 319篇 |
神经病学 | 1310篇 |
特种医学 | 1992篇 |
外国民族医学 | 1篇 |
外科学 | 2246篇 |
综合类 | 3037篇 |
现状与发展 | 4篇 |
预防医学 | 1156篇 |
眼科学 | 358篇 |
药学 | 3300篇 |
6篇 | |
中国医学 | 1117篇 |
肿瘤学 | 594篇 |
出版年
2024年 | 16篇 |
2023年 | 283篇 |
2022年 | 437篇 |
2021年 | 803篇 |
2020年 | 716篇 |
2019年 | 676篇 |
2018年 | 737篇 |
2017年 | 692篇 |
2016年 | 727篇 |
2015年 | 800篇 |
2014年 | 1552篇 |
2013年 | 1671篇 |
2012年 | 1438篇 |
2011年 | 1622篇 |
2010年 | 1265篇 |
2009年 | 1196篇 |
2008年 | 1301篇 |
2007年 | 1211篇 |
2006年 | 1006篇 |
2005年 | 920篇 |
2004年 | 744篇 |
2003年 | 679篇 |
2002年 | 592篇 |
2001年 | 433篇 |
2000年 | 377篇 |
1999年 | 313篇 |
1998年 | 307篇 |
1997年 | 308篇 |
1996年 | 296篇 |
1995年 | 307篇 |
1994年 | 270篇 |
1993年 | 248篇 |
1992年 | 196篇 |
1991年 | 196篇 |
1990年 | 142篇 |
1989年 | 115篇 |
1988年 | 137篇 |
1987年 | 86篇 |
1986年 | 106篇 |
1985年 | 107篇 |
1984年 | 104篇 |
1983年 | 63篇 |
1982年 | 67篇 |
1981年 | 81篇 |
1980年 | 59篇 |
1979年 | 49篇 |
1978年 | 42篇 |
1977年 | 27篇 |
1976年 | 20篇 |
1971年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的:探讨脑出血对酵母沉默信息调节因子2(Sirt2)和炎症的影响。方法:将胶原酶Ⅳ注入SD大鼠右侧
纹状体中建立脑出血模型,通过免疫印迹和ELISA 等方法测定大鼠脑出血后48 h 的Sirt2 的表达及炎症变化。利
用Hemin 诱导PC12 细胞损伤模拟体外脑出血模型,并检测Sirt2 及炎症变化;采用短发夹RNA(shRNA)-Sirt2 沉
默Sirt2 在PC12 细胞中的表达及对炎症的影响。结果:手术后48 h 脑出血行为学评分最低。脑出血组Sirt2 的表达
显著高于假手术组。脑出血组IL-6、IL-1β 表达显著升高。结论:脑出血可以促进Sirt2 的表达和炎症反应,降低
Sirt2 的表达可减缓炎症反应。
关键词 脑出血;沉默信息调节 相似文献
3.
4.
Defects of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) protein affect the homeostasis of chloride, bicarbonate, sodium, and water in the airway surface liquid, influencing the mucus composition and viscosity, which induces a severe condition of infection and inflammation along the whole life of CF patients. The introduction of CFTR modulators, novel drugs directly intervening to rescue the function of CFTR protein, opens a new era of experimental research. The review summarizes the most recent advancements to understand the characteristics of the infective and inflammatory pathology of CF lungs. 相似文献
5.
6.
7.
《Neuromodulation》2021,24(8):1336-1340
BackgroundThe use of implantable pulse generators (IPG) for spinal cord stimulation (SCS) in patients with chronic pain has been well established. Although IPG-related complications have been reported on, the association between IPG site and SCS complications has not been well studied.ObjectiveTo investigate whether IPG placement site in buttock or flank is associated with SCS complications and, hence, revision surgeries.MethodA retrospective cohort study was performed that included 330 patients (52% female) treated at a single institution who underwent permanent implantation of an SCS system between 2014 and 2018. Patients ranged between 20 and 94 years of age (mean: 57.54 ± 13.25). Statistical analyses were conducted using IBM SPSS Statistics. Tests included independent samples t test, chi-square test, Mann–Whitney U test, Spearman’s rank correlation coefficient, and logistic regression.ResultsThere was a total of 93 revision surgeries (rate of 28%), where 71 out of 330 patients (rate of 21.5%) had had at least one revision surgery. Univariate tests demonstrated a significant association between IPG site and revision surgeries (p = 0.028 [chi-square test] and p = 0.031 [Mann–Whitney U test]); however, multivariate logistic regression demonstrated that neither IPG site was more likely than the other to require revision surgeries (p = 0.286).ConclusionAlthough this study found a significant association between IPG site and revision surgeries, the effect of IPG site was not found to be predictive. The IPG site likely influences whether a patient will require revision surgery, but further investigation is required to establish this association. 相似文献
8.
刘光 ' target='_blank'> 刘支娜 ' target='_blank'> 张玲 ' target='_blank'> 王会瑟 ' target='_blank'> 蔺颐 ' target='_blank'> 张亚涛 ' target='_blank'> 陶金 ' target='_blank'> 刘闯 ' target='_blank'> 《现代肿瘤医学》2021,(2):323-326
目的:探讨基于脉压变异度(PPV)的目标导向液体治疗(GDFT)在腹膜后巨大恶性肿瘤切除术患儿中的应用。方法:择期行腹膜后巨大恶性肿瘤切除术患儿64例,年龄0.5~3岁,ASA Ⅱ-Ⅲ级。随机将患儿分为目标导向液体治疗组(G组)和常规液体治疗组(C组),每组32例。G组以PPV为指导,根据GDFT方案进行液体管理,C组采用常规液体管理。记录手术开始(T1)、手术开始后1 h(T2)、手术结束(T3)的MAP、CVP、PPV、Lac值、TNF-α、IL-6浓度。记录术中输注晶体液量、胶体液量、液体总量、出血量、尿量、手术时间、多巴胺使用率以及排气时间、术后住院时间和恶心呕吐发生率。结果:G组输注晶体液量显著少于C组(P<0.05),而输注胶体液量显著多于C组(P<0.05)。两组术中输注液体总量、出血量、尿量与多巴胺使用率方面差异无统计学意义。T2、T3时刻,G组PPV、TNF-α、IL-6显著低于C组(P<0.05),而两组间MAP、CVP、Lac在各时点差异无统计学意义。G组术后排气时间明显短于C组(P<0.05),而在术后恶心呕吐发生率和住院时间方面两组差异无统计学意义。结论:PPV指导的GDFT可以应用于腹膜后巨大恶性肿瘤切除术患儿,能维持其血流动力学稳定,减少炎症因子IL-6、TNF-α释放,促进胃肠功能恢复,但对术后转归无明显影响。 相似文献
9.
10.
Could non-HDL-cholesterol be a better marker of atherogenic dyslipidemia in obstructive sleep apnea?
《Sleep medicine》2021
Background/objectiveObstructive sleep apnea (OSA) is independently associated with dyslipidemia, a surrogate marker of atherosclerosis. Low-density lipoprotein (LDL)-cholesterol is accepted as a major independent risk factor for cardiovascular disease. However, non-high-density lipoprotein (HDL)-cholesterol is a better marker of atherogenic dyslipidemia and recommended as a target of lipid lowering therapy. We aimed to assess the prevalence of atherogenic dyslipidemia, and relationship between OSA severity and serum LDL-cholesterol and non-HDL cholesterol levels in OSA patients.MethodsWe retrospectively evaluated treatment naïve 2361 subjects admitted to the sleep laboratory of a university hospital for polysomnography. All subjects’ lipid profile including total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, and non-HDL-cholesterol were measured.ResultsOut of 2361 patients (mean age 49.6 ± 11.9 years; 68.9% male, apnea-hypopnea index 36.6 ± 28.4/h), 185 (7.8%) had no OSA and 2176 (92.2%) had OSA. Atherogenic dyslipidemia prevalence was high (57–66%) in OSA patients, and especially increased in severe OSA compared to other groups (p < 0.05). Though total and LDL-cholesterol did not differ between those with and without OSA, non-HDL-cholesterol (p = 0.020), and triglycerides (p = 0.001) were higher and HDL-cholesterol levels (p = 0.018) were lower in OSA patients than non-OSA. Non-HDL-cholesterol was significantly correlated with OSA severity (p < 0.001) and hypoxia parameters (p < 0.01), whereas LDL-cholesterol showed no correlation.ConclusionsAtherogenic dyslipidemia is highly prevalent and non-HDL-cholesterol levels are significantly increased, predominantly in severe OSA patients. Non-HDL-cholesterol but not LDL-cholesterol, is significantly correlated with OSA severity and hypoxia parameters. Therefore, it could be better to use non-HDL-cholesterol, which is a guideline recommended target of lipid therapy, as a marker of atherosclerotic cardiovascular risk in OSA patients. 相似文献